Marek Disease Market to Reflect a Holistic Expansion During 2022-2028 | Pfizer Inc, Sanofi-Aventis U.S., Merck & Co., Inc., Virbac,

Growing prevalence of zoonotic disease to propel Marek disease market growth

Market Overview:

Marek's Disease is a herpes virus infection majorly occur in chickens. The disease cause tumors on eyes, nerves, skin, and internal organs of chicken.

Competitive Landscape:

Pfizer Inc, Sanofi-Aventis U.S., Merck & Co., Inc., Virbac, and Bayer Healthcare. For instance, cell-associated vaccines like CVI988/Rispens are highly effective for Marek's disease, thus marking a drastic disease reduction in broiler and layer flocks.

Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/794

Key Drivers

Growing prevalence of zoonotic disease is a prime factor driving growth of the Marek disease market. Rising consumer concern over food safety is again anticipated to foster market growth. High livestock production is further projected to augment market growth.

Increasing consumption of animal protein and growing prevalence of food borne disease is again projected to propel market growth. Per capita availability of animal protein in high-income countries is expected to grow slowly over the coming decade (1.8 grams per person per day, or three per cent), according to the DownToEarth report. More people in these countries will replace red meat with poultry meat or dairy products due to health and environmental reasons.

Covid-19 Impact Analysis

The outbreak of Covid-19 pandemic is intricately linked to biodiversity loss and ecosystem health. This has driven the emergence of biodiversity conservation and environmental policies to save the biodiversity from zoonotic disease. In order to prevent the emergence of zoonosis and their effects on human health World Health Organization has taken action to safeguard the biodiversity.

Request Here PDF Brochure Of This Report @ https://www.coherentmarketinsights.com/insight/request-pdf/794

Key Takeaways:

1. Regional segmentation of the global marek disease market by Coherent Market Insights comprises North America, Latin America, Asia-Pacific, Europe, and the Middle East and Africa.

2. North America is expected to gain significant growth over the forecast period owing to the growing animal health awareness, increasing research to offer genetic resistance via vaccines, and growing number of biosecurity programs.

Buy This Research Study Report With Flat USD 2000 OFF @ https://www.coherentmarketinsights.com/promo/buynow/794

About US:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact Us:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This release was published on openPR.